Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50.
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012;42(6):563–70.
Pantalone KM, Hobbs TM, Chagin KM, et al. Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open. 2017;7(11):e017583.
PubMed PubMed Central Article Google Scholar
Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33.
CAS PubMed Article Google Scholar
Kivimaki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022.
•• Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859–76. Nice summary of the contribution of obesity, inflammation, and hypertension to the development and progression of chronic renal disease.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.
CAS PubMed Article Google Scholar
Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207(6):928–34.
Bays HE, Chapman RH, Grandy S, Group SI. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737–47.
CAS PubMed Article Google Scholar
Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world–a growing challenge. N Engl J Med. 2007;356(3):213–5.
CAS PubMed Article Google Scholar
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289(2):187–93.
Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673.
PubMed PubMed Central Article Google Scholar
Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280–7.
PubMed PubMed Central Article Google Scholar
DeVallance E, Fournier SB, Donley DA, et al. Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors? Int J Obes (Lond). 2015;39(2):244–53.
Ndumele CE, Matsushita K, Lazo M, et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc. 2016;5(8).
Gill D, Zuber V, Dawson J, et al. Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis. Int J Obes (Lond). 2021;45(7):1428–38.
Stenholm S, Head J, Aalto V, et al. Body mass index as a predictor of healthy and disease-free life expectancy between ages 50 and 75: a multicohort study. Int J Obes (Lond). 2017;41(5):769–75.
Lumsden RH, Pagidipati NJ, Phelan MP, Chiswell K, Peterson ED. Prevalence and management of adult obesity in a large U.S. Academic Health System. Am J Prev Med. 2020;58(6):817–24.
Lemay CA, Cashman S, Savageau J, Fletcher K, Kinney R, Long-Middleton E. Underdiagnosis of obesity at a community health center. J Am Board Fam Pract. 2003;16(1):14–21.
Bray GA, Kim KK, Wilding JPH, World Obesity F. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–23.
CAS PubMed Article Google Scholar
Velazquez A, Apovian CM. Updates on obesity pharmacotherapy. Ann N Y Acad Sci. 2018;1411(1):106–19.
Ammori BJ, Skarulis MC, Soran H, Syed AA, Eledrisi M, Malik RA. Medical and surgical management of obesity and diabetes: what’s new? Diabet Med. 2020;37(2):203–10.
CAS PubMed Article Google Scholar
Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324(12):1190–200.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1–8.
Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment–a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring). 2013;21(1):8–24.
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991–1006.
CAS PubMed PubMed Central Article Google Scholar
Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951–68.
CAS PubMed PubMed Central Article Google Scholar
Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of hypertension: the mosaic theory and beyond. Circ Res. 2021;128(7):847–63.
CAS PubMed PubMed Central Article Google Scholar
Shams E, Kamalumpundi V, Peterson J, Gismondi RA, Oigman W, de Gusmao Correia ML. Highlights of mechanisms and treatment of obesity-related hypertension. J Hum Hypertens. 2022.
Oliveira V, Kwitek AE, Sigmund CD, Morselli LL, Grobe JL. Recent advances in hypertension: intersection of metabolic and blood pressure regulatory circuits in the central nervous system. Hypertension. 2021;77(4):1061–8.
CAS PubMed Article Google Scholar
Kaze AD, Musani SK, Bidulescu A, et al. Plasma leptin and blood pressure progression in Blacks: the Jackson Heart Study. Hypertension. 2021;77(4):1069–75.
CAS PubMed Article Google Scholar
Weisbrod RM, Shiang T, Al Sayah L, et al. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension. 2013;62(6):1105–10.
CAS PubMed Article Google Scholar
Agbaje AO, Barker AR, Tuomainen TP. Effects of arterial stiffness and carotid intima-media thickness progression on the risk of overweight/obesity and elevated blood pressure/hypertension: a cross-lagged cohort study. Hypertension. 2022;79(1):159–69.
CAS PubMed Article Google Scholar
Izzo R, Losi MA, Stabile E, et al. Development of left ventricular hypertrophy in treated hypertensive outpatients: the Campania Salute Network. Hypertension. 2017;69(1):136–42.
CAS PubMed Article Google Scholar
Lonnebakken MT, Mancusi C, Losi MA, et al. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: the Campania Salute Network. Nutr Metab Cardiovasc Dis. 2019;29(2):185–90.
CAS PubMed Article Google Scholar
de Simone G, Devereux RB, Izzo R, et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013;2(3):e000144.
PubMed PubMed Central Article Google Scholar
Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 1991;266(2):231–6.
CAS PubMed Article Google Scholar
Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21(10):1144–51.
Turkbey EB, McClelland RL, Kronmal RA, et al. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging. 2010;3(3):266–74.
PubMed PubMed Central Article Google Scholar
Neeland IJ, Gupta S, Ayers CR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging. 2013;6(5):800–7.
PubMed PubMed Central Article Google Scholar
Wilner B, Garg S, Ayers CR, et al. Dynamic relation of changes in weight and indices of fat distribution with cardiac structure and function: the Dallas Heart Study. J Am Heart Assoc. 2017;6(7).
Cai A, Liu L, Zhou D, Zhou Y, Tang S, Feng Y. The patterns of left ventricular alteration by adipose tissue distribution: implication for heart failure prevention. ESC Heart Fail. 2021;8(4):3093–105.
PubMed PubMed Central Article Google Scholar
Sciacqua A, Cimellaro A, Mancuso L, et al. Different patterns of left ventricular hypertrophy in metabolically healthy and insulin-resistant obese subjects. Nutrients. 2020;12(2).
Efremov L, Lacruz ME, Tiller D, et al. Metabolically healthy, but obese individuals and associations with echocardiographic parameters and inflammatory biomarkers: results from the CARLA Study. Diabetes Metab Syndr Obes. 2020;13:2653–65.
CAS PubMed PubMed Central Article Google Scholar
Berenson GS, Srinivasan SR. Emergence of obesity and cardiovascular risk for coronary artery disease: the Bogalusa Heart Study. Prev Cardiol. 2001;4(3):116–21.
留言 (0)